Detalhe da pesquisa
1.
Restricted Palivizumab Recommendations and the Impact on RSV Hospitalizations among Infants Born at > 29 Weeks of Gestational Age: An Italian Multicenter Study.
Am J Perinatol
; 36(S 02): S77-S82, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31238365
2.
Interaction between healthcare professionals and parents is a key determinant of parental distress during childhood hospitalisation for respiratory syncytial virus infection (European RSV Outcomes Study [EROS]).
Acta Paediatr
; 107(5): 854-860, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29341239
3.
Outcomes of Infants Receiving Palivizumab Prophylaxis for Respiratory Syncytial Virus in Canada and Italy: An International, Prospective Cohort Study.
Pediatr Infect Dis J
; 36(1): 2-8, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27649365